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The mouse homologue of human Langerin (CD207), a novel Langerhans cells (LC)-restricted C-type lectin that
likely participates in antigen recognition and uptake, has been recently identiﬁed. In this study, we isolated the
mouse Langerin cDNA from murine fetal skin-derived dendritic cells (FSDDC) by subtractive cloning and rapid
ampliﬁcation of cDNA ends (RACE). An alternatively spliced variant of mouse Langerin that lacked the extracellular
neck domain (DE3Langerin) was detected in RNA derived from FSDDC and epidermal LC by RT-PCR. In vitro-
generated FSDDC and epidermal LC expressed both full-length and DE3Langerin mRNA, but tissue expression was
not restricted to skin. Mouse Langerin protein isoforms were readily detected in ﬁbroblasts transfected with cDNAs
encoding epitope-tagged Langerin and DE3Langerin. Recombinant DE3Langerin protein localized with transferrin-
containing compartments in transfected ﬁbroblasts. Full-length mouse Langerin-bound mannan, whereas
DE3Langerin and soluble bacterial recombinant Langerin protein lacking the neck domain did not. Fibroblasts
transfected with mouse Langerin cDNA contained typical Birbeck granules (BG) and cored tubules, whereas
DE3Langerin cDNA did not induce BG or cored tubule formation in transfected ﬁbroblasts. Developmentally
regulated expression of Langerin isoforms provides a mechanism by which Langerin involvement in antigen uptake
and processing could be regulated.
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Dendritic cells (DC) comprise a heterogeneous population
of bone marrow-derived cells that possess the ability to
take up and process antigens, and the unique capacity to
prime naı¨ve T cells (Steinman, 1991; Hart, 1997). Epidermal
Langerhans cells (LC) represent the prototype of immature
DC in peripheral tissues. Ultrastructurally, LC are distin-
guished from other immature DC by the presence of
Birbeck granules (BG), distinctive endocytic vesicles that
appear as intracellular rod-shaped structures with periodi-
cally striated lamella in transmission electron micrographs
(Birbeck et al, 1961; Wolff, 1967). LC reside within epidermis
for long periods of time, enabling them to perform a key role
in cutaneous immunosurveillance. After encountering and
acquiring exogenous antigens, LC are activated and
migrate to regional lymph nodes, where they present
antigens to T cells and initiate primary immune responses
(Stingl, 1993; Udey, 1997). Antigen uptake by immature DC
occurs via phagocytosis, fluid-phase pinocytosis (Sallusto
et al, 1995), and receptor-mediated endocytosis (Hartgers
et al, 2000; Thery et al, 2001).
LC express several receptors that facilitate antigen
recognition and uptake, including C-type lectins. C-type
lectins bind carbohydrates in a calcium-dependent manner
via their carbohydrate recognition domains (CRD) and are
widely conserved in animals, plants, and microorganisms
(Lis et al, 1998). The mammalian C-type lectins are
subgrouped based on functional and structural features
into collectins, selectins, and endocytic receptors (Kishore
et al, 1997; Weis et al, 1998). They recognize glycosylated
proteins and mediate processes such as cellular recognition
and adhesion, and receptor-mediated endocytosis. Based
on their structure, transmembrane C-type lectins can be
subdivided into type I C-type lectins with an extracellular
amino (N) terminus and multiple CRD, and type II C-type
lectins with an intracellular N-terminus and a single
extracellular CRD that is tethered to the membrane by
a-helical regions of varying length.
LC express both type I and type II C-type lectins. DEC-
205 is a type I C-type lectin that is weakly expressed by
resting LC, and is more abundantly expressed by activated
DC (Jiang et al, 1995; Kato et al, 2000). Type II C-type
lectins found on LC include the DC-associated C-type
lectin-1 (Dectin-1 (Yokota et al, 2001)) and Langerin
(Valladeau et al, 1999, 2000). Langerin (CD207) is a novel
C-type lectin that bears the Lag antigen (Kashihara et al,
1986), is selectively expressed by human LC and is
associated with BG and cored tubules in human LC
(Valladeau et al, 2000, 2001; Lipsker et al, 2003). The
mouse homologue of human Langerin has been identified
and has been shown to be associated with BG formation
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EC, epidermal cell; ECD, extracellular domain; FSDDC, fetal skin-
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and the occurrence of cored tubules (Valladeau et al, 2002).
Although physiologic ligands have not been identified, it is
presumed that Langerin is involved in antigen uptake and
processing. Herein we report the identification of a spliced
isoform of mouse Langerin that is expressed in fetal skin-
derived dendritic cells (FSDDC) and epidermal LC and that
functionally differs from full-length Langerin.
Results
Identiﬁcation of an alternatively spliced mouse Langerin
transcript To identify genes that were preferentially ex-
pressed by epidermal LC, we constructed a subtractive
cDNA library from FSDDC and mouse inflammatory skin
macrophages and sequenced 548 potentially independent
clones. Forty-two of the sequenced clones were homo-
logous to human Langerin. A homology search with murine
EST from Genbank showed an overlap with two EST
sequences, AA764540 and AA423304. We compiled a
nucleotide sequence of 576 bp to design 50- and 30-
RACE-PCR primers (RACE, rapid amplification of cDNA
ends) and, by RACE-PCR, cloned a cDNA corresponding to
full-length mouse Langerin (Takahara et al, 2002; Valladeau
et al, 2002).
RT PCR using MHC class IIþ LC-enriched epidermal
cells (EC) and FSDDC total RNA with Langerin primers
regularly revealed multiple bands of consistent sizes in
addition to the expected full-length product of 996 bp (Fig
1A). To further characterize these products, bands were
excised, cloned, and sequenced. Sequence analysis of 621
bp clones revealed a mouse Langerin cDNA isoform that
lacks exon 3 (DE3Langerin, Fig 1B) and is predicted to
encode a protein lacking the neck domain. Sequencing of
clones obtained from 810 bp bands predicted a nonsense
protein with a premature stop due to a frameshift within the
coding region (data not shown).
Cell and tissue distribution of mouse Langerin tran-
scripts Quantitative RT-PCR was performed to assess
Langerin mRNA expression levels within different cell types
and tissues. The primers that were used for the detection of
full-length Langerin mRNA bind within the 30 prime UTR and
therefore did not differentiate between different isoforms.
FSDDC expressed abundant amounts of total mouse
Langerin mRNA, whereas two other DC cell lines (XS52
and XS106) did not (Fig 2A). Upon lipopolysaccharide
(LPS)-induced maturation of FSDDC, Langerin mRNA was
downregulated (Fig 2A). As shown in Fig 2B, high levels of
Langerin mRNA were detected in freshly isolated MHC
class IIþ epidermal LC (fLC) and were strongly down-
regulated upon culture. To assess mRNA expression levels
of DE3Langerin, we designed a forward primer that
spanned exons 2 and 4 and therefore selectively amplified
the exon 3-deficient isoform of mouse Langerin. DE3Lan-
gerin mRNA was differentially expressed in FSDDC and LC
as compared with total Langerin. Total Langerin mRNA was
more abundant in fLC than FSDDC. In contrast, FSDDC
expressed high levels of DE3Langerin mRNA, whereas LC
showed very low levels of mRNA expression (Fig 2C).
DE3Langerin mRNA was undetectable in enriched LC that
had been cultured for 48 h (Fig 2C). Figure 2D depicts the
expression pattern of total mouse Langerin mRNA in various
tissues. As expected, a strong signal for Langerin mRNA
could be detected in skin. In accordance with the expres-
sion pattern of human Langerin mRNA, mouse Langerin
mRNA was also strongly represented in lung. Interestingly,
we also found high expression levels of mouse Langerin
mRNA in thymus. Finally, low levels of Langerin mRNA were
detected in spleen, heart, kidney, liver, and stomach
(Fig 2D). Mouse skin contained low levels of DE3Langerin
mRNA. Comparable expression levels were found in lung,
thymus, and heart (Fig 2E). These findings indicate that
mouse Langerin expression is not restricted to skin and that
the newly identified spliced isoform of mouse Langerin is
detectable not only in FSDDC, but in primary LC and in
various mouse tissues as well.
Expression of DE3Langerin protein in ﬁbroblasts Lan-
gerin protein is associated with BG in human LC (Valladeau
et al, 2000). To study effects of expression of mouse
Langerin proteins, we transfected COS-1 cells with full-
length Langerin cDNA and DE3Langerin cDNA, respectively,
fused to sequences encoding a C-terminal V5 epitope. RT-
PCR with DE3Langerin-specific primers showed a single
band in DE3Langerin cDNA-transfected COS-1 cells, but
not in cells that were transfected with a control vector (Fig
3A). Transfection efficiencies were evaluated by FACS
analysis using a mAb against the V5 epitope (Fig 3B).
Transfection efficiencies obtained with the two-mouse
Langerin constructs and levels of protein expression on
the cell surface of transfected fibroblasts were similar.
Subcellular distribution of recombinant DE3Langerin
protein To assess protein distribution in DE3Langerin
cDNA-transfected COS-1 fibroblasts, cells that had been
fixed and permeabilized were stained with an anti-mouse
Langerin peptide antibody reactive with a C-terminal
sequence of the protein, and the subcellular distribution of
Figure 1
Identification of an alternatively spliced mouse Langerin tran-
script. (A) Ethidium bromide-stained agarose gel showing PCR
products for full-length mouse Langerin obtained from C57BL/6 fresh
LC (fLC) and from fetal skin-derived dendritic cells (FSDDC). (B) The
diagrams illustrate the contributions of various exons to the indicated
mouse Langerin isoforms (full-length (fl) Langerin and DE3Langerin).
Boxes denote exons (1–6 in full-length Langerin). The cross indicates
spliced out exon 3 in DE3Langerin.
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DE3Langerin was examined by confocal microscopy.
Reactivity with the Langerin antibody was readily detected
on cell surfaces of transfected cells and within the
cytoplasm in a granular cytoplasmic staining pattern (Fig
4B, C). FACS analysis of transfectants that had been
stained with anti-V5 mAb directed against the C-terminal
epitope of recombinant DE3Langerin protein confirmed
surface expression of DE3Langerin (Fig 3B). To determine
if DE3Langerin protein is localized within the endosomal
compartment as it has been shown for human Langerin
protein by McDermott et al (2002), the uptake of rhodamine
transferrin in COS-1 cells transfected with DE3Langerin was
monitored. As shown in Fig 4, 5 min after the addition of
rhodamine transferrin most of the fluorescence signal was
observed in the perinuclear region (Fig 4D). DE3Langerin
protein co-localized to a considerable degree with rhoda-
mine transferrin in COS-1 cells (Fig 4E, F). This data mirrors
the distribution of Langerin in human epidermal LC
(McDermott et al, 2002) and in human Langerin-transfected
COS-1 cells (E. Riedl and M. C. Udey, unpublished
observations).
Capacity of mouse Langerin isoforms to induce BG
formation Transfection of mouse fibroblasts with human
and mouse Langerin cDNA leads to the induction of BG
(Valladeau et al, 2000, 2002). To evaluate the role of mouse
Langerin isoforms in the formation of BG, the morphological
hallmark of LC, we transiently transfected COS-1 cells with
full-length mouse Langerin cDNA and DE3Langerin cDNA.
Transfection of COS-1 cells with full-length mouse Langerin
resulted in the formation of rod-shaped structures with a
central periodically striated lamella within the cytoplasm
that were readily identified as typical BG (Fig 5B). Identical
structures were formed in COS-1 cells transfected with
Figure 2
Cell and tissue distribution of mouse
Langerin transcripts. (A) Comparative ana-
lysis of total Langerin mRNA expression
levels between non-stimulated and lipopoly-
saccharide (LPS)-stimulated fetal skin-de-
rived dendritic cell (FSDDC) and two other
DC lines (XS106, XS52). (B) Comparison of
mouse total Langerin mRNA expression
levels between C57BL/6 FSDDC (ns, non-
stimulated) and freshly isolated LC (fLC)
versus LC that had been enriched on day 0
and then cultured for 48 h (cLC). (C)
Comparison of DE3Langerin mRNA expres-
sion levels in the same samples as in (B).
Results are expressed relative to expression
in FSDDC (A–C). (D) Total Langerin mRNA
expression in various tissues. (E) DE3Langer-
in mRNA expression in various tissues.
Results are expressed relative to expression
in skin (D, E). One representative experiment
is shown; (A) n¼ 3; (B, C) n¼2; (D) n¼ 5, (E)
n¼ 3.
Figure3
Transfection of fibroblasts with Langerin
cDNA. (A) PCR analysis of COS-1 cells that
have been either transfected with a LacZ
encoding control vector (LacZ) or with DE3-
Langerin cDNA (DE3) and amplified with
either GAPDH primers (upper panel) or with
spliced Langerin primers (lower panel). (B)
FACS analysis for V5-epitope expression in
non-transfected COS-1 cells (n.t.) and cells
that have been either transfected with full-
length Langerin cDNA or with DE3Langerin
cDNA.
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human Langerin cDNA (data not shown). In some mouse
Langerin transfectants, dramatically elongated BG-like
structures were observed (Fig 5D). Strikingly, some of the
mouse Langerin-transfected cells displayed multiple curvi-
linear and circular structures within the cytoplasm (Fig 5A,
E). These structures, though reminiscent of BG, displayed
at higher magnification tubular formations consisting of
limiting unit membranes with dense central cores (see
arrowheads in Fig 5E), as has been described for ‘‘cored
tubules’’ in LC in vivo (Kobayashi and Hoshino, 1978).
Fibroblasts that had been transfected with DE3Langerin
cDNA did not contain BG, BG-like structures, or cored
tubules (Fig 5B).
Mannan-binding capacity of mouse Langerin isoforms
Mouse Langerin has been shown to possess mannan-
binding capacity, most likely via its EPN motif within the
CRD domain of the protein (Takahara et al, 2002).
Furthermore, oligomerization through the formation of a-
helical coiled-coils within the neck domain is a prerequisite
for efficient sugar binding of type II C-type lectins (Weis
et al, 1996). This would predict reduced or absent sugar-
binding capacity of the DE3Langerin protein. To test this
hypothesis, we transiently transfected COS-1 cells with V5-
tagged recombinant full-length mouse Langerin and DE3-
Langerin cDNAs, and incubated detergent-solubilized cell
lysates with mannan agarose. As shown in Fig 6A,
recombinant full-length Langerin protein bound to mannan
agarose, whereas the neck domain-deficient DE3Langerin
protein did not. The necessity of the neck domain was
additionally addressed by expressing recombinant proteins
consisting either of the neck domain and the CRD of mouse
Figure 4
Subcellular distribution of DE3Langerin
protein and co-localization with rhoda-
mine transferrin. COS-1 cells that had been
transfected with DE3Langerin (B–F) and non-
transfected cells (A) were fixed and permea-
bilized and stained with anti-Langerin anti-
body followed by fluorescein isothiocyanate
(FITC)-conjugated anti-chicken ab. (A) Non-
transfected COS-1cells did not react with
anti-Langerin antibody. (B, C) Subcellular
distribution of DE3Langerin protein in trans-
fected cells. (D–F) DE3Langerin-transfected
COS-1 cells were incubated with rhodamine
transferrin for 5 min. Cells were fixed and
stained with anti-Langerin antibody followed
by FITC-conjugated anti-chicken ab. Magni-
fication  40 (A, B). Magnification  60 (C).
Magnification  20 (D–F).
Figure 5
Capacity of Langerin isoforms to induce
Birbeck granules (BG) formation. (A) Full-
length Langerin cDNA-transfected cells con-
tains a tubular network that can be identified
as cored tubules at higher magnification (E).
(B) DE3Langerin–COS-1 transfectant. (C)
Full-length Langerin transfectant with typical
BG. (D) Elongated BG-like structures in full
length Langerin transfectants. Magnification:
(A, B)  5000; (C, D)  40,000; (E) 20,000.
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Langerin or the CRD alone in Escherichia coli, and
assessing the mannan-binding capacity of these recombi-
nant bacterial proteins. Figure 6C shows that mannan
binding was dramatically reduced or absent in the protein
lacking the neck domain despite the presence of the EPN
motif within the CRD. The presence of the CRD and the
neck domain was sufficient for obvious mannan binding to
occur (Fig 6B).
Discussion
In this study, we identified and characterized a novel
isoform of mouse Langerin, a new member of the C-type
lectin family. Mouse Langerin is a type II transmembrane
protein with an extracellular a-helical neck domain and a
CRD containing a mannan-binding site, and is highly
homologous to its human counterpart (Weis et al, 1998).
The newly identified isoform of mouse Langerin, termed
DE3Langerin, lacks the neck domain. Mouse Langerin
mRNA is preferentially expressed by LC in vivo, and
DE3Langerin mRNA was detected in RNA isolated from
FSDDC and epidermal LC. DE3Langerin protein lacked the
capacity to bind mannan agarose. Finally, transfection of
fibroblasts with full-length mouse Langerin cDNA-induced
BG and cored tubule formation, whereas DE3Langerin-
transfected cells did not contain BG or cored tubules.
Structural features of mouse Langerin isoforms Both
mouse and human Langerin genes are comprised of six
exons, with three exons encoding the ECD of the protein.
This feature is shared with several other type II C-type
lectins including the murine Kupffer cell receptor (KCR)
(Hoyle et al, 1991), dectin-1 and dectin-2 (Ariizumi et al,
2000a, b), CD23 (Beavil et al, 1992), hepatic asialoglyco-
protein receptor (ASGPR) (Spiess, 1990), DC-SIGN (Geij-
tenbeek et al, 2000), and DC-SIGNR (Soilleux et al, 2000).
Another unifying characteristic of this subgroup is a single
exon-encoded neck domain that is interposed between the
transmembrane domain and the CRD. Mouse Langerin
contains a heptad repeat motif within the neck domain that
may direct a-helical coiled-coil formation (Kammerer, 1997).
a-Helical coiled-coil stalks are also found in other C-type
lectins, where they seem to be involved in receptor
oligomerization (Beavil et al, 1992). The hepatic ASGPR is
composed of two homologous polypeptides, HL1 and HL2,
that form a hetero-oligomeric complex (Lodish, 1991). Both
subunits are required to form high-affinity receptors (Bider
et al, 1996). Splice variants of the human ASGPR H2 subunit
that differ within the neck domain and generate either a
soluble, secreted proteolytic fragment or associate with H1
to form a functional plasma membrane receptor have been
described (Tolchinsky et al, 1996; Shenkman et al, 1997). By
analogy, it is tempting to speculate that mouse Langerin
forms homo/hetero-oligomers on cell surfaces and that full-
length Langerin is but one chain of a multimeric functional
endocytic receptor. This study describes a novel splice
variant of mouse Langerin. In addition to the full-length
molecule, we identified a cDNA isoform that is predicted to
encode a protein that lacks the neck domain. Deletion of the
neck domain by alternative splicing has been shown
recently for two other C-type lectins that are expressed by
DC, notably dectin-1 (Yokota et al, 2001) and dectin-2
(Ariizumi et al, 2000a). Alternative splicing has also been
reported for other type II C-type lectins, including the low-
affinity IgE receptor, CD23 (Nunez et al, 1995), the B cell-
associated lectin CD72 (Ying et al, 1995), and the NK-cell
receptor CD94 (Furukawa et al, 1998). The two isoforms of
mouse Langerin may delineate LC that are at different
stages of maturation or may be involved in differential
regulation of endocytic activity in different tissues.
Langerin isoforms are differentially expressed in
FSDDC, LC, and various mouse tissues FSDDC share
many morphological and functional features with LC in vivo
(Jakob et al, 1997, 1998). FSDDC expressed abundant
amounts of mouse Langerin mRNA that was rapidly down-
regulated upon LPS-induced maturation. Freshly isolated
LC also expressed much higher levels of mouse Langerin
mRNA than LC that had been cultured for 48 h. These
findings are consistent with the observations that human
Figure 6
Binding to mannan agarose by Langerin isoforms. (A) Cell lysates of
full-length Langerin-transfected cells (FL) and DE3Langerin-transfected
cells (DE3) were incubated with mannan-agarose beads (lanes 1, 2) or
not (lanes 3, 4) and bound fractions were analyzed by immunoblotting.
(B, C) Purification of Langerin fragments by affinity chromatography on
mannan agarose. Langerin carbohydrate recognition domain (CRD) and
extracellular domain (ECD) were expressed in 1 L bacterial culture.
Loaded samples (S), flow through fraction (FT), first and last 1 mL wash
fractions (W1, W2) and 2  6 mL elution fractions (E1, E2) were
collected. (B) ECD fragments. (C) CRD fragments. The concentration of
loaded samples for ECD and CRD fragments was 0.3 mg per mL and
0.35 mg per mL, each. Fractions were separated on denatured SDS-
PAGE and detected by immunoblotting using anti-Langerin Ab.
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Langerin protein is associated with BG in LC in vivo
(Valladeau et al, 2000; Lipsker et al, 2003) and that BG
numbers decrease upon LC maturation (Stossel et al, 1990).
Stoitzner et al (2003) investigated mouse Langerin expres-
sion at the protein level. In accordance with our data they
found a decrease in Langerin protein expression upon
culture of LC. Interestingly, we detected DE3Langerin
mRNA not only in FSDDC, but also in fresh LC, albeit at
low levels. DE3Langerin was not detectable in cultured LC.
These findings suggest that DE3Langerin is physiologically
relevant. Furthermore, one could speculate that this isoform
is associated with a more immature phenotype, since
mRNA levels were highest in FSDDC and were absent in
cultured LC. The fact that the spliced isoform of mouse
Langerin has not been detected by two other groups that
described mouse Langerin, may relate to the sources of
Langerin containing cells used in the different studies
(Takahara et al, 2002;Valladeau et al, 2002). FSDDC display
features of very immature LC and contain the highest
amount of Langerin mRNA, whereas epidermal LC that
rapidly undergo maturational changes during the isolation
procedure might contain much lower levels of DE3Langerin
mRNA. Thus, the spliced isoform of mouse Langerin might
be difficult to detect in PCR gels from whole EC suspen-
sions or other sources of LC.
When we quantified mRNA of mouse Langerin transcripts
in a variety of mouse tissues, we found that in accordance
with other studies (Takahara et al, 2002;Valladeau et al,
2002), mouse Langerin mRNA expression was not restricted
to skin and lung, as it had been described for human
Langerin (Valladeau et al, 2000), but that varying amounts of
Langerin mRNA could be detected in many of the tissues
analyzed. The highest expression levels of mouse Langerin
mRNA were found in lung and thymus. These organs
expressed also the highest levels of DE3Langerin mRNA.
BG-containing immature DC have been described within
human and mouse thymus (Ardavin, 1997), and Langerin-
expressing DC have been identified in human lung epithe-
lium (Valladeau et al, 1999) and in mouse lung and thymus
(Takahara et al, 2002;Valladeau et al, 2002). Expression of
mouse Langerin mRNA in spleen, heart, and stomach is
consistent with the presence of immature DC in virtually all
organs except the brain, parts of the eye, and the testis
(Hart, 1997) and their role as sentinels of the immune system
(Steinman, 1991). Immature DC, like LC, are proficient in
antigen uptake, and C-type lectins such as Langerin are
expected to play important roles in this process. Valladeau
et al (1999, 2000) reported that anti-Langerin mAb-induced
Langerin internalization did not result in co-localization of
Langerin with MHC class II molecules, suggesting an
alternative route for Langerin-associated antigens, possibly
via the MHC class I pathway. In fact, McDermott et al (2002)
demonstrated that Langerin protein traffics through the
recycling compartment of freshly isolated human LC. In
accordance with their data, we observed that in COS-1 cells
DE3Langerin protein co-localized with transferrin-containing
endosomes. The fact that we could not detect DE3Langerin
mRNA in all organs that expressed mouse Langerin might
be due to very low expression levels in some tissues.
Alternatively, it is possible that Langerin isoforms are differ-
entially expressed in different organs.
Mouse Langerin isoforms differ in their capacity to
induce BG formation and mannan binding Mouse and
human Langerin share the capacity to induce BG formation
(Valladeau et al, 2000, 2002). Introduction of mouse
Langerin cDNA into COS-1 cells led to the accumulation
of typical BG; however, we also observed numerous tubular
curvilinear structures in the perinuclear area within these
cells. These structures appear to correspond to ‘‘cored
tubules’’, structures that have been previously described in
human LC (Hanau et al, 1988; Lipsker et al, 2003) and in
mouse DC (Kobayashi and Hoshino, 1978; Bucana et al,
1992) in the dermis and the draining lymph nodes, although
these cells contained either cored tubules or BG (Kobayashi
and Hoshino, 1983). The significance of cored tubules is
unknown. Lipsker et al (2003) demonstrated the co-
existence of both BG and cored tubules within freshly
isolated human LC and observed reactivity of cored tubules
with anti-Langerin and anti-CD1a antibodies at 371C
suggesting that cored tubules form part of the early
recycling compartment in LC. Valladeau et al (2002) have
suggested that a point mutation within the CRD of mouse
Langerin promotes accumulation of similar structures in
transfected fibroblasts. But in accordance with the findings
of Lipsker et al (2003), we observed BG and cored tubules in
fibroblasts transfected with wild-type mouse Langerin.
Fibroblasts that had been transfected with DE3Langerin
cDNA contained neither BG nor cored tubules, although the
staining pattern of DE3Langerin protein not only showed
surface expression, but a clear intracellular localization of
the protein as well.
Functional consequences related to the loss of the neck
domain were demonstrated in a mannan-agarose binding
assay. Mouse Langerin binds to mannan, consistent with
the presence of residues necessary for Ca2þ -dependent
binding of mannose and related sugars (Weis et al, 1992;
Takahara et al, 2002). Stambach et al (2003) demonstrated
for human Langerin that trimerization of Langerin through its
neck domain is a prerequisite for efficient oligosaccharide
binding. Thus, it was not surprising that DE3Langerin was
not able to bind mannan agarose. Mannan-binding experi-
ments with recombinant bacterial proteins confirmed this
finding and suggest that as has been shown for human
Langerin (Stambach et al, 2003), mouse Langerin must form
multimers in order to efficiently bind to and endocytose
mannose-containing structures. The identification of an
isoform in mouse Langerin that lacks the neck domain and
differs in function and expression from the full-length
Langerin, adds additional complexity to Langerin physiol-
ogy. The presence of DE3Langerin in cells of some tissues
might alter ligand binding, uptake, and processing by
immature DC. Alternatively, the splice variant may reflect
the presence of very immature LC or LC precursors and
thus provide a new tool to discriminate between different
maturation stages of LC.
Materials and Methods
Cells and cell lines FSDDC were isolated as aggregates from
GM-CSF and CSF-1-supplemented primary cultures of day 16
C57BL/6 or BALB/c murine fetal skin as previously described
(Jakob et al, 1997). COS-1 cells were obtained from the American
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Tissue Type Collection (ATCC, Manassas, Virginia) and cultured in
complete DMEM. XS106 and XS52 cells were graciously provided
by Dr Akira Takashima (University of Texas-Southwestern, Dallas,
Texas). EC were isolated from ear skin of C57BL/6 and BALB/c
mice using sequential treatment with trypsin (Amersham Pharma-
cia Biotech, Piscataway, New Jersey) and DNase I (Sigma, St
Louis, Missouri) as previously described (Stingl et al, 1981).
Enriched LC were prepared by magnetic activated cell-sorting
(MACS) (Miltenyi Biotec, Bergisch Gladbach, Germany) sorting
with fluorescein isothiocyanate (FITC)-conjugated anti-mouse Ia
mAb (clone 2G9, BD Pharmingen, San Diego, California), and anti-
FITC microbeads (Miltenyi Biotec). Cell cultures were performed in
RPMI-1640 containing 5% FBS, glutamine, penicillin/stretomycin,
and lipopolysaccharide (100 ng per mL) for 48 h.
Cloning of mouse Langerin cDNA A cDNA library enriched in LC
transcripts was constructed by subtracting the cDNA prepared
from pooled FSDDC poly-A RNA samples with pooled poly-A
RNAs isolated from polyacrylamide-bead-elicited skin macro-
phages (Belkaid et al, 1998) using a PCR Select Kit (Clontech,
Palo Alto, California). The complete nucleotide sequence of mouse
Langerin cDNA was obtained using the FirstChoice RLM-RACE Kit
(Ambion, Austin, Texas). Total RNA from FSDDC (1 mg) was treated
with DNAse I (Ambion) prior to mRNA purification. 30 and 50 RACE
products were amplified as described by the manufacturer, using
gene-specific primers for 50-RACE (50-GTAGAGAAACTTTTGTTCC-
GATTC-30 and 50-TACAGAACTGCTCTGCGCTGTA-30) and 30-
RACE (50-AATGACAGATCTGGCCTGAGC-30 and 50-GCTCCAA-
GATTGCTCTGTACT-30). PCR products were separated on agarose
gels and a putative mouse Langerin cDNA was isolated and ligated
into TOPO TA-vector (Invitrogen, Carlsbad, California) for DNA
sequencing (Seqwright, Houston, Texas).
RT-PCR analysis and cloning of spliced variants Total RNA was
extracted from BALB/c and C57BL/6 FSDDC and from C57BL/6
MHC class IIþ LC. Full-length Langerin cDNA with BamH1 and
Not1 flanking sites was synthesized using RT for PCR kit (Perkin-
Elmer, Wellesly, Massachusetts). PCR was performed in a PTC-200
DNA Engine Thermal Cycler (MJ Research, Waltham, Massachu-
setts) for 35 cycles (30 s denaturation at 941C, 30 s annealing at
681C, 3 min extension at 681C) using specific primers for the 50 and
30 UTR sequences deduced from the RACE products (forward
50-CGGATCCGACCATGCCAGAGGCAGATGAA-30, reverse 50-AA-
GCGGCCGCTTCAGTTGTTTGGACGTA-30). Fragments were re-
solved in 2% agarose gels. For identification of splice variants,
the respective PCR products were purified and ligated into TOPO
TA-vector (Invitrogen) for DNA sequencing (Lofstrand Labs Limited,
Gaithersburg, Maryland).
Semi-quantitative and RT-PCR analysis Primers for RT-PCR
quantitation of mouse Langerin mRNA were developed according
to recommended criteria using the ABI PRISM Primer Express
software (Perkin-Elmer, Applied Biosystems, Foster City, California).
For mouse Langerin tissue distribution studies, Rapid-Scan mouse
cDNA panels (OriGene Tech., Rockville, Maryland) were used. To
amplify total Langerin mRNA, primers that bound within the 30-UTR
were used (forward 50-CGTCCAAACAACTGAATGACAGA-30, re-
verse 50-GACATCTCTTCAGCCAGGTCACT-30). For detection of
DE3 Langerin mRNA, the following primer pair was used: forward
50-TTCAGGCTGTTTTCTGTGACATT-30, reverse 50-TCTGCGCTGT-
ACCAGGTCTTT-30). TaqMan PCR was performed in 50 mL reaction
volumes using 1  Sybr Green PCR Mastermix (Perkin-Elmer) in
the presence of 200 nM of forward and reverse primers. Thermal
cycling and quantitation of fluorescence were performed with an
ABI PRISM 7700 Sequence Detection System (Applied Bio-
systems). Threshold cycle numbers (Ct) were determined with
Sequence Detector Software (version 1.6; Applied Biosystems)
and transformed using the DDCt method as described by the
manufacturer using GAPDH as the calibration cDNA.
Transient transfection of mouse ﬁbroblasts BamH1 and Not1
flanked mouse full-length Langerin and DE3Langerin cDNAs from
FSDDC were cloned into BamH1 and Not1 sites of the mammalian
expression vector pcDNA3.1V5/His (Invitrogen) and transiently
transfected into COS-1 cells using Fugene6 reagent (Roche
Applied Science, Indianapolis, Indiana). Non-transfected COS-1
cells and transiently transfected COS-1 cells (48–72 h) were
stained with mouse mAb V5 (Invitrogen) or mouse IgG2a isotype
control mAb, followed by FITC-conjugated goat F(ab’)2 anti-mouse
immunoglobulins (Jackson ImmunoResearch, West Grove, Penn-
sylvania) and analyzed by analytical flow cytometry (FACS).
Expression analysis of DE3 Langerin protein by confocal
microscopy For immunofluorescence staining, DE3Langerin
cDNA-transfected and non-transfected COS-1 cells were allowed
to adhere to polylysine-coated glass slides. Subsequently, cells
were fixed and permeabilized using Fix&Perm (Caltag, Burlingame,
California) according to the manufacturer’s instructions. To detect
DE3 Langerin protein in transfected cells, we used a custom-made
polyclonal chicken anti-mouse Langerin peptide antibody gener-
ated against a synthetic peptide corresponding to a 10-amino acid
sequence (CKRPYVQTTE) near the C-terminus of mouse Langerin
(Aves Labs, Inc., Tigard, Oregon). This antibody recognizes not
only the neck-deficient isoform of mouse Langerin, but also the
full-length molecule and therefore cannot distinguish between the
two isoforms. As isotype control, non-immune chicken antibodies
(chicken IgY, Aves Labs) were used. Cells were subsequently
stained with FITC-conjugated goat anti-chicken antibodies (Aves
Labs). Coverslips were mounted onto glass slides with ProLong
Antifade (Molecular Probes, Eugene, Oregon). Analysis of stained
cells was performed using a Personal Confocal Laser (PCL)
microscope (Nikon, Tokyo, Japan).
Rhodamine-transferrin uptake and immunoﬂuorescence mi-
croscopy To assess the subcellular distribution of DE3Langerin
protein, DE3Langerin cDNA-transfected and non-transfected
COS-1 cells were serum starved in DMEM containing 5% bovine
serum albumin (Sigma) for 2 h. They were then incubated in the
presence of 5 mg per mL of human rhodamine transferrin
(Molecular Probes) for 5 min. Subsequently, cells were fixed and
permeabilized using Fix&Perm (Caltag) and stained with the anti-
Langerin antibody followed by FITC-conjugated goat anti-chicken
antibody (Aves Labs). Cells were analyzed using confocal micro-
scopy.
Transmission electron microscopy Transfected cells were fixed
in neutral-buffered 2.5% glutaraldehyde, embedded in agar, post-
fixed with 1% osmium tetroxide, block stained in uranyl acetate,
processed through graded solutions of ethanol and propylene
oxide, and embedded in Spurr’s epoxy. One-micron semi-thick
plastic sections were cut with glass knives and stained with
toluidine blue for viewing by light microscopy. Selected blocks
were thin sectioned, stained with uranyl acetate and lead citrate
and examined on an electron microscope operating at 60 kV (LEO
Electron Microscopy Ltd, Thornwood, New York).
Immunoblotting and mannan-agarose-binding studies Wes-
tern blot analysis for V5-tagged mouse Langerin protein and
DE3Langerin protein was performed using COS-1 cell detergent
lysates. SDS-PAGE was performed with NuPAGE 4%–12% Bis–
Tris gels and MOPS running buffer (Invitrogen). Samples were
blotted with anti-V5 mAb (Invitrogen) or isotype control mAb
(Pharmingen), horseradish peroxidase (HRP)-conjugated anti-
mouse IgG (Santa Cruz Biotech, Santa Cruz, California) and
SuperSignal Chemoluminiscent Substrate (Pierce, Rockford, Illi-
nois). Mannan-agarose binding studies were performed as
previously described with modifications (Takahara et al, 2002).
Transfectants were lysed in 1 mL lysis buffer (50 mM Tris-HCl (pH
7.6), 150 mM NaCl, 25 mM CaCl2, 0.05% Triton-X, 1 mM PMSF,
and 20 mg per mL aprotinin) for 1 h on ice. After a centrifugation
step, the lysate was collected and diluted 5-fold with binding buffer
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(lysis buffer without Triton X). Five hundred microliters of the lysate
was incubated with 20 mL of mannan-agarose beads (Sigma-
Aldrich, St Louis, Missouri) for 12 h at 41C. Subsequently, several
washing steps with binding buffer removed non-bound fractions.
Bound proteins were separated by 12% SDS-PAGE under
denaturing conditions. Samples were blotted with anti-V5 mAb
(Invitrogen) as described above.
Expression and puriﬁcation of soluble Langerin frag-
ments The region of the cDNA coding for the CRD and for the
extracellular domain of Langerin (ECD) were PCR-amplified using
the following primer sets: forward 50-GCGGATCCCCTAGGTTG-
ATGGGCAAAATA-30 and reverse 50-AAAAGCTTTCACTCCAGAAT-
GTCACTCTG-30 for Langerin ECD; forward 50-TTGGATCCT-
TAATGGTGGCTCGAGGCTGG-30 and the reverse primer as de-
scribed above for Langerin CRD. The primers included restriction
sites for BamHI and HindIII. PCR was performed for 30 cycles
(1 min denaturation at 941C, 1 min annealing at 601C, 3 min extention
at 721C). PCR products were cloned into pET-30a (þ ) vector
(Novagen, Madison, Wisconsin), and verified by DNA sequencing.
The plasmids were subsequently used to transform Escherichia
coli BL21/DE3. Recombinant proteins were isolated from the E. coli
cell pellets as previously described with modifications (Stambach
et al, 2003). Briefly, the pellet was solubilized in 6 M Guanidine-HCl,
20 mM Tris-HCl, pH 8.0, 500 mM NaCl buffer and purified using
Ni2þ -nitrilotriacetic acid resin (Novagen). After extensive dialysis
against 25 mM Tris-HCl, pH 8.0, 150 mM NaCl, 25 mM CaCl2
(loading buffer), insoluble precipitate was removed by centrifuga-
tion at 100,000  g for 1 h at 41C. The supernatant was loaded
onto a 5-mL column of mannan agarose (Sigma-Aldrich) pre-
equilibrated with loading buffer. The column was washed with 25
mL loading buffer and eluted with 2  6 mL elution buffer (25 mM
Tris-HCl, pH 8.0, 150 mM NaCl, 10 mM EDTA). Fractions were
analyzed by immunoblotting using anti-Langerin Ab.
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